No Picture
Articles

FDA issues warning about PPIs and C. difficile infections

BIG NEWS related to Treatment of Acid Reflux
FDA issues warning about PPIs and C. difficile infections

On February 8, 2012 the US Food and Drug Administration issued a safety alert to physicians and consumers, which stated that the use of PPIs to reduce acid production by the stomach may be associated with an increased risk for developing persistent diarrhea and other GI symptoms due to infection with a bacteria called Clostridium difficile, or C. diff. Read the FDA report. In a related story carried by Reuters, March 6, 2012, reporter Julie Steenhuyse discribes the increasing incidence and virulence of C.diff infections. […]